Our case report that is the first published case series in which Grade IV hepatic GVHD, refractory to steroids, tacro, and rux, demonstrating a CR to pulse Cytoxan. Cheap therapy, strong responses ⬇️💰#oncopharm https://t.co/onOMcYRhDW
595 followers
12,167 followers
RT @FrontOncology: New research: Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host dise…
6,533 followers
New research: Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease: Graft-versus-host disease (GVHD) is a common complication in patients receiving allogeneic hematopoietic stem cell… https://t.co/Qs